Rupiah slide drives up drug costs, burdening chronically ill patients

Tulus Abadi, chairman of the Indonesian Consumers Foundation (FKBI), said soaring medicine and vitamin prices were an unavoidable consequence of the rupiah’s depreciation, noting that between 85 and 90 percent of the raw materials used by Indonesia’s pharmaceutical industry are imported.